LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”

November 20, 2024

We’re thrilled to announce that LinusBio has been honored as the “Overall MedTech Company of the Year” by the 2024 BioTech Breakthrough Awards! This award highlights our precision exposome sequencing technology from a strand of hair mapping an individual’s unique biological response to facilitate discovery across various health conditions.

The BioTech Breakthrough Awards celebrate excellence across life sciences and biotechnology, and we’re honored to stand alongside our esteemed peers in the industry. Thank you to our dedicated team and partners for helping us drive forward the possibilities in medical technology.

By analyzing strands of hair, LinusBio’s exposomic platform delivers deep, longitudinal information about a person’s environmental exposures and metabolic reactions. This information generates new biomarkers that can diagnose disease, optimize clinical trials and provide environmental context to make genomics even more powerful.


Do you find this article interesting? Share it:

Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair

LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation